Document is current
Any future updates will be listed below
-
Authors
Yadav, Tara Chand
Mohiyuddin, Shanid
Hildebrandt, Gerhard C.
Palaniyandi, Senthilnathan
-
Funding
Funding for this research was provided by:
University of Missouri
- License Information
-
More Information
Article History
Received: 13 November 2025
Accepted: 27 May 2026
First Online: 3 June 2026
Competing interests
: G.C.H. received preclinical research funding from Aceta Pharma and Incyte, and advisory roles in the field of GVHD with Incyte. Stocks from Pfizer, Kite Pharma, Incyte, Jazz Pharmaceuticals, Morphosys, Alexion Pharmaceuticals, Daichiy, Karyopharm Therapeutics, Seattle Genetics, Jannsen Pharmaceuticals, RAPA Therapeutics, Ono Pharmaceutical, AstraZeneca, and CTI BioPharma Corp. S.P. received preclinical research funding from Aceta Pharma and Incyte. Other authors declare no conflict of interest.
